TrialThe Lancet. Respiratory medicine2022

Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.

Nicola K Love et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.